CMMB
Chemomab Therapeutics
CMMB
CMMB
9 hedge funds and large institutions have $5.22M invested in Chemomab Therapeutics in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PCM
1
Palisade Capital Management
Fort Lee,
New Jersey
|
$1.66M |
| 2 |
MIH
2
Meitav Investment House
Bene-Beraq,
Israel
|
$1.74M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
| $1.74M | 387,402 | +361,315 | +1,385% |
|
|
PCM
2
Palisade Capital Management
Fort Lee,
New Jersey
| $1.66M | 369,640 | +369,640 | New |
|
|
KCM
3
Kennedy Capital Management
St Louis,
Missouri
| $891K | 198,841 | -1,159 | -0.6% |
|
|
AIC
4
AWM Investment Company
New York
| $448K | 100,000 | – | – |
|
|
RI
5
RTW Investments
New York
| $233K | 51,918 | -8,496 | -14% |
|
6
Fidelity Investments
Boston,
Massachusetts
| $132K | 29,300 | -13,700 | -32% |
|
|
DG
7
Delek Group
Herzliya,
Israel
| $114K | 26,087 | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $6K | 1,418 | -1,317 | -48% |
|
|
CCA
9
Catalyst Capital Advisors
Huntington,
New York
| – | – | -500 | Closed |
|
|
CFGS
10
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $0 | 60 | +60 | New |
|